Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Leukemia

• Publication date

  2016-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2015.294PMID 26500142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Induced Pluripotent Stem Cell-Derived B Lymphocytes Express sIgM and Can Be Generated via a Hemogenic Endothelium Intermediate

  2015cited by this paper
• The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fate

  2015cited by this paper
• HOXA9 promotes hematopoietic commitment of human embryonic stem cells.

  2014cited by this paper
• Reliable Generation of Induced Pluripotent Stem Cells From Human Lymphoblastoid Cell Lines

  2014cited by this paper
• Fast and Efficient Neural Conversion of Human Hematopoietic Cells

  2014cited by this paper
• Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.

  2013cited by this paper
• The role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells.

  2013cited by this paper
• An Efficient Nonviral Method to Generate Integration‐Free Human‐Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells

  2013cited by this paper
• C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells

  2013cited by this paper
• Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation.

  2013cited by this paper
• Response: the role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells.

  2013cited by this paper
• SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells.

  2012cited by this paper
• Maintenance of Human Embryonic Stem Cells in Mesenchymal Stem Cell-Conditioned Media Augments Hematopoietic Specification

  2012cited by this paper
• Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.

  2012cited by this paper
• Maintenance of Human Embryonic Stem Cells in Media Conditioned by Human Mesenchymal Stem Cells Obviates the Requirement of Exogenous Basic Fibroblast Growth Factor Supplementation

  2012cited by this paper
• Residual Expression of the Reprogramming Factors Prevents Differentiation of iPSC Generated from Human Fibroblasts and Cord Blood CD34+ Progenitors

  2012cited by this paper
• Efficient Reprogramming of Human Cord Blood CD34+ Cells Into Induced Pluripotent Stem Cells With OCT4 and SOX2 Alone.

  2012cited by this paper
• CCAAT/enhancer binding protein α (C/EBPα)-induced transdifferentiation of pre-B cells into macrophages involves no overt retrodifferentiation

  2011cited by this paper
• Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures

  2011cited by this paper
• Harnessing the potential of induced pluripotent stem cells for regenerative medicine

  2011cited by this paper
• Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells.

  2011cited by this paper
• Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells

  2011cited by this paper
• Reprogramming of human peripheral blood cells to induced pluripotent stem cells.

  2010cited by this paper
• Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.

  2010cited by this paper
• Development of Defective and Persistent Sendai Virus Vector

  2010cited by this paper
• Human Induced Pluripotent Stem Cells Develop Teratoma More Efficiently and Faster Than Human Embryonic Stem Cells Regardless the Site of Injection

  2010cited by this paper
• iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability

  2010cited by this paper
• Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.

  2010cited by this paper
• Butyrate Greatly Enhances Derivation of Human Induced Pluripotent Stem Cells by Promoting Epigenetic Remodeling and the Expression of Pluripotency‐Associated Genes

  2010cited by this paper
• Induced pluripotent stem cells: epigenetic memories and practical implications.

  2010cited by this paper
• PI3 kinase signals BCR-dependent mature B cell survival.

  2009cited by this paper
• Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells

  2009cited by this paper
• Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2.

  2009cited by this paper
• Cancer Genes Hypermethylated in Human Embryonic Stem Cells

  2008cited by this paper
• Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.

  2008cited by this paper
• Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

  2008cited by this paper
• Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential.

  2005cited by this paper
• Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma.

  2005cited by this paper
• Recombinant Sendai virus vectors for activated T lymphocytes

  2003cited by this paper
• Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936

  2003cited by this paper
• Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

  2001cited by this paper
• Development and selection of T cells: facts and puzzles.

  1995cited by this paper
• T-cell antigen receptor genes and T-cell recognition

  1988cited by this paper
• Brief report Generation of induced pluripotent stem cells from human blood

  year unknowncited by this paper

• HLA-DRB1 Impact on Survival of Induced Leukemic Cells Under ‘Allergic’ Conditions

  2025cites this paper
• The reprogramming factor KLF4 in normal and malignant blood cells

  2025cites this paper
• The occurrence and development of induced pluripotent stem cells

  2024cites this paper
• Induced Pluripotent Stem Cells Facilitate the Development and Evaluation of Cancer Vaccines.

  2024cites this paper
• Manipulating cell fate through reprogramming: approaches and applications.

  2024cites this paper
• Generation of immune cells from induced pluripotent stem cells (iPSCs): Their potential for adoptive cell therapy.

  2024cites this paper
• Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives

  2023cites this paper
• Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges

  2023cites this paper
• ABO gene editing for the conversion of blood type A to universal type O in Rhnull donor‐derived human‐induced pluripotent stem cells

  2022cites this paper
• Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP‐IGH fusion gene

  2022cites this paper
• Primary B cell engineering for therapeutic research.

  2022cites this paper
• Functional genomic approaches in acute myeloid leukemia: Insights into disease models and the therapeutic potential of reprogramming.

  2022cites this paper
• How induced pluripotent stem cells changed the research status of polycystic ovary syndrome

  2022cites this paper
• Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies

  2021cites this paper
• TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes.

  2021cites this paper
• Human stem cell‐based models for studying host‐pathogen interactions

  2021cites this paper
• Muse cells as a robust source of induced pluripotent stem cells

  2021cites this paper
• Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD‐L1 expression

  2020cites this paper
• A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine

  2020cites this paper
• Toward a better definition of hematopoietic progenitors suitable for B cell differentiation

  2020cites this paper
• Application of induced pluripotent stem cell technology for the investigation of hematological disorders.

  2019cites this paper
• Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions

  2019cites this paper
• Reprogramming of bone marrow derived mesenchymal stromal cells to human induced pluripotent stem cells from pediatric patients with hematological diseases using a commercial mRNA kit.

  2019cites this paper
• Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector

  2019cites this paper
• Human iPSC banking: barriers and opportunities

  2019cites this paper
• Immortalized murine fibroblast cell lines are refractory to reprogramming to pluripotent state

  2018cites this paper
• C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1

  2018cites this paper
• A protocol for generating induced T cells by reprogramming B cells in vivo

  2018cites this paper
• Monocyte‐Specific Knockout of C/ebpα Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebpα in Osteoclast Differentiation and Function

  2018cites this paper
• Human acute leukemia induced pluripotent stem cells: a unique model for investigating disease development and pathogenesis.

  2017cites this paper
• Establishment of induced pluripotent stem cells from normal B cells and inducing AID expression in their differentiation into hematopoietic progenitor cells

  2017cites this paper
• Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformation.

  2017influential citation
• Generation, genome edition and characterization of iPSC lines from a patient with coenzyme Q10 deficiency harboring a heterozygous mutation in COQ4 gene.

  2017cites this paper
• Efficient transduction of melanoma cells with Sendai viral vectors

  2017cites this paper
• Mitochondria and stem cell function: from somatic cells to iPSC-based disease modeling

  2017influential citation
• Genetic Rescue of Mitochondrial and Skeletal Muscle Impairment in an Induced Pluripotent Stem Cells Model of Coenzyme Q10 Deficiency

  2017cites this paper
• Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the “safe harbor” AAVS1 locus

  2017cites this paper
• Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas

  2017cites this paper
• Induced pluripotent stem cell technology: A window for studying the pathogenesis of acquired aplastic anemia and possible applications.

  2017cites this paper
• Cell Line Generation and characterization of a human iPSC cell line expressing inducible Cas 9 in the “ safe harbor ” AAVS 1 locus

  2017influential citation
• Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines

  2016cites this paper
• Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency

  2016cites this paper
• Cellular Ontogeny and Hierarchy Influence the Reprogramming Efficiency of Human B Cells into Induced Pluripotent Stem Cells

  2016cites this paper
• Potential Cancer Prevention and Treatment by Silencing the Killer Cell Immunoglobulin-like Receptor Gene in Natural Killer Cells Derived from Induced Pluripotent Stem Cells.

  2016cites this paper
• C/EBPα creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4

  2016cites this paper
• Regulatory Mechanisms in Biosystems

  year unknowninfluential citation